Viewing Study NCT00684593


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-05-22 @ 2:43 PM
Study NCT ID: NCT00684593
Status: COMPLETED
Last Update Posted: 2019-02-05
First Post: 2008-05-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: P04481
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators